|
|
|
Insider
Information: |
Paul Steven M |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
1,185,025 |
|
Indirect Shares
|
632,151 |
|
|
Direct
Value |
$40,560,036 |
|
|
Indirect Value
|
$33,183,610 |
|
|
Total
Shares |
1,817,176 |
|
|
Total
Value |
$73,743,646 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
EVP, Science and Techn... |
2010-02-01 |
38,897 |
2010-02-01 |
39,040 |
Premium* |
|
Sigma-Aldrich Corp |
SIAL |
Director |
2015-11-18 |
0 |
2007-01-02 |
0 |
Premium* |
|
Sage Therapeutics, Inc. |
SAGE |
|
2019-03-21 |
272,777 |
2022-11-28 |
593,111 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2022-04-01 |
1,000 |
2015-01-26 |
0 |
Premium* |
|
Voyager Therapeutics, Inc. |
VYGR |
President and CEO, Dir... |
2016-01-14 |
872,351 |
|
0 |
Premium* |
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2024-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
131 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
officerTitle |
|
2006-02-02 |
4 |
S |
$57.00 |
$353,457 |
D/D |
(6,201) |
89,656 |
|
- |
|
LLY |
Eli Lilly & Co |
officerTitle |
|
2005-12-15 |
4 |
OE |
$34.59 |
$453,475 |
D/D |
13,110 |
90,202 |
|
- |
|
LLY |
Eli Lilly & Co |
officerTitle |
|
2006-02-01 |
4 |
D |
$56.62 |
$158,479 |
D/D |
(2,799) |
95,857 |
|
- |
|
LLY |
Eli Lilly & Co |
officerTitle |
|
2006-01-20 |
4 |
A |
$57.04 |
$1,230,011 |
D/D |
21,564 |
98,656 |
|
- |
|
KRTX |
Karuna Therapeutics, Inc. |
President & CEO |
|
2019-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
96,485 |
106,485 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
CSO and President of R&D |
|
2022-05-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
106,485 |
106,485 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
CSO and President of R&D |
|
2022-05-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
106,485 |
106,485 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
PRESIDENT & CEO |
|
2021-08-17 |
4 |
B |
$105.63 |
$124,960 |
I/I |
1,183 |
107,668 |
0.01 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
PRESIDENT & CEO |
|
2021-08-18 |
4 |
B |
$106.10 |
$125,304 |
I/I |
1,181 |
108,849 |
0.01 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-02-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
122,400 |
119,295 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-03-21 |
4 |
AS |
$161.02 |
$1,268,824 |
I/I |
(7,879) |
122,400 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-03-20 |
4 |
AS |
$161.20 |
$9,136,582 |
I/I |
(56,646) |
130,279 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, Science and Technology |
|
2007-05-21 |
4 |
OE |
$54.80 |
$5,370,838 |
D/D |
98,008 |
138,140 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-03-18 |
4 |
AS |
$161.01 |
$607,977 |
I/I |
(3,775) |
186,925 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-03-01 |
4 |
AS |
$161.00 |
$418,600 |
I/I |
(2,600) |
190,700 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-02-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
122,400 |
193,300 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-02-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
241,695 |
241,695 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
241,695 |
272,777 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2018-03-06 |
4 |
AS |
$172.00 |
$9,999,908 |
D/D |
(58,139) |
632,712 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2016-02-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,081 |
678,569 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2015-09-01 |
4 |
AS |
$52.10 |
$1,048,184 |
D/D |
(20,000) |
683,650 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2017-01-31 |
4 |
A |
$3.15 |
$6,848 |
D/D |
2,174 |
690,851 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2015-08-03 |
4 |
AS |
$66.42 |
$1,341,692 |
D/D |
(20,000) |
703,650 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2015-07-01 |
4 |
AS |
$67.46 |
$1,388,028 |
D/D |
(20,000) |
723,650 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2015-06-01 |
4 |
AS |
$71.36 |
$1,446,799 |
D/D |
(20,000) |
743,650 |
0 |
- |
|
131 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|